Ian Lewis

2.3k total citations · 1 hit paper
26 papers, 1.9k citations indexed

About

Ian Lewis is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ian Lewis has authored 26 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Epidemiology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ian Lewis's work include Neuroendocrine Tumor Research Advances (11 papers), Chemical Synthesis and Analysis (9 papers) and Pituitary Gland Disorders and Treatments (8 papers). Ian Lewis is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Chemical Synthesis and Analysis (9 papers) and Pituitary Gland Disorders and Treatments (8 papers). Ian Lewis collaborates with scholars based in Switzerland, United States and Netherlands. Ian Lewis's co-authors include Christian Bruns, Gisbert Weckbecker, U. Briner, Guy Meno‐Tetang, Rainer Albert, Daniël Hoyer, Herbert Schmid, Janos Pless, W. Bauer and Nagarajan Chandramouli and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Clinical Endocrinology & Metabolism and Nature Reviews Drug Discovery.

In The Last Decade

Ian Lewis

25 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

2002 555 citations Christian Bruns, Ian Lewis et al. European Journal of Endocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ian Lewis Switzerland	17	922	794	566	397	340	26	1.9k
U. Briner Switzerland	13	1.2k 1.3×	868 1.1×	570 1.0×	587 1.5×	468 1.4×	23	2.2k
W. Bauer Switzerland	8	747 0.8×	433 0.5×	735 1.3×	387 1.0×	241 0.7×	15	1.7k
Janos Pless Switzerland	12	722 0.8×	425 0.5×	954 1.7×	391 1.0×	232 0.7×	15	2.0k
Guy Meno‐Tetang United States	13	347 0.4×	356 0.4×	419 0.7×	238 0.6×	231 0.7×	21	1.2k
Zoltán Rékási United States	19	167 0.2×	725 0.9×	370 0.7×	290 0.7×	101 0.3×	38	1.2k
Renzo Cescato Switzerland	25	1.5k 1.6×	167 0.2×	583 1.0×	1.5k 3.7×	506 1.5×	46	2.7k
Susana R�os United Kingdom	20	131 0.1×	127 0.2×	961 1.7×	195 0.5×	109 0.3×	39	1.9k
Alejandra Tomás United Kingdom	27	111 0.1×	698 0.9×	1.5k 2.7×	233 0.6×	38 0.1×	61	2.4k
Olaf Prante Germany	29	208 0.2×	89 0.1×	858 1.5×	694 1.7×	42 0.1×	110	2.5k
Seema S. Deshpande United States	8	144 0.2×	87 0.1×	692 1.2×	200 0.5×	158 0.5×	10	1.3k

Countries citing papers authored by Ian Lewis

Since Specialization

Citations

This map shows the geographic impact of Ian Lewis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Lewis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Lewis more than expected).

Fields of papers citing papers by Ian Lewis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Lewis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Lewis. The network helps show where Ian Lewis may publish in the future.

Co-authorship network of co-authors of Ian Lewis

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Lewis. A scholar is included among the top collaborators of Ian Lewis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Lewis. Ian Lewis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagdanoff, Jeffrey T., Thomas M. Smith, Martin Allan, et al.. (2023). Clearance of plasma PCSK9 via the asialoglycoprotein receptor mediated by heterobifunctional ligands. Cell chemical biology. 30(1). 97–109.e9. 22 indexed citations

Furet, Pascal, Bahaâ Salem, Yannick Mesrouze, et al.. (2019). Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence. Bioorganic & Medicinal Chemistry Letters. 29(16). 2316–2319. 33 indexed citations

Vorherr, Thomas, Ian Lewis, Michael Schaefer, et al.. (2019). Spätphasenfunktionalisierung von Peptiden und Cyclopeptiden mithilfe von Organozinkreagenzien. Angewandte Chemie. 131(24). 8316–8320. 7 indexed citations

Vorherr, Thomas, Ian Lewis, Joerg Berghausen, Sandrine Desrayaud, & Michael Schaefer. (2017). Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic Hexapeptides. International Journal of Peptide Research and Therapeutics. 24(1). 35–48. 22 indexed citations

Hoegenauer, Klemens, Nicolas Soldermann, Gregory J. Hollingworth, et al.. (2016). Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 26(23). 5657–5662. 17 indexed citations

Hoegenauer, Klemens, Nicolas Soldermann, Frédéric Stauffer, et al.. (2016). Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. ACS Medicinal Chemistry Letters. 7(8). 762–767. 49 indexed citations

Lewis, Ian, Herbert Schmid, Rainer Kneuer, et al.. (2014). SOM230: A New Therapeutic Modality for Cushing's Disease. CHIMIA International Journal for Chemistry. 68(7-8). 483–483. 4 indexed citations

Renner, Steffen, Ansgar Schuffenhauer, Werner Breitenstein, et al.. (2011). Recent Trends and Observations in the Design of High-Quality Screening Collections. Future Medicinal Chemistry. 3(6). 751–766. 44 indexed citations

Thoma, Gebhard, Ian Lewis, Darryl Jones, et al.. (2011). Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood. Bioorganic & Medicinal Chemistry Letters. 21(16). 4745–4749. 7 indexed citations

10.

Thoma, Gebhard, Ian Lewis, Trixie Wagner, et al.. (2009). Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: Discovery, characterization and preliminary SAR of a promising lead. Bioorganic & Medicinal Chemistry Letters. 19(21). 6185–6188. 12 indexed citations

11.

Lewis, Ian, Rainer Albert, Rainer Kneuer, et al.. (2005). Medicinal chemistry of somatostatin analogs leading to the DTPA and DOTA conjugates of the multi-receptor-ligand SOM230.. PubMed. 28(11 Suppl International). 15–20. 6 indexed citations

12.

Hoek, Joost van der, Aart‐Jan van der Lelij, Richard A. Feelders, et al.. (2005). The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients. Clinical Endocrinology. 63(2). 176–184. 46 indexed citations

13.

Lewis, Ian, et al.. (2005). Correction: Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nature Reviews Drug Discovery. 4(12). 1026–1026. 1 indexed citations

14.

Murray, Robert, Kiwon Kim, Song-Guang Ren, et al.. (2004). The Novel Somatostatin Ligand (SOM230) Regulates Human and Rat Anterior Pituitary Hormone Secretion. The Journal of Clinical Endocrinology & Metabolism. 89(6). 3027–3032. 69 indexed citations

15.

Hoek, Joost van der, Wouter W. de Herder, Richard A. Feelders, et al.. (2004). A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients. The Journal of Clinical Endocrinology & Metabolism. 89(2). 638–645. 117 indexed citations

16.

Weckbecker, Gisbert, Ian Lewis, Rainer Albert, et al.. (2003). Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nature Reviews Drug Discovery. 2(12). 999–1017. 444 indexed citations

17.

Lewis, Ian, W. Bauer, Rainer Albert, et al.. (2003). A Novel Somatostatin Mimic with Broad Somatotropin Release Inhibitory Factor Receptor Binding and Superior Therapeutic Potential. Journal of Medicinal Chemistry. 46(12). 2334–2344. 99 indexed citations

18.

Hannon, Jason, Caroline Nunn, Barbara Stolz, et al.. (2002). Drug Design at Peptide Receptors. Journal of Molecular Neuroscience. 18(1-2). 15–28. 91 indexed citations

19.

Bruns, Christian, Ian Lewis, U. Briner, Guy Meno‐Tetang, & Gisbert Weckbecker. (2002). SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. European Journal of Endocrinology. 146(5). 707–716. 555 indexed citations breakdown →

20.

Lewis, Ian. (1993). Peptide analogues of DNA incorporating nucleobase-Ala-Pro subunits. Tetrahedron Letters. 34(36). 5697–5700. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact